Oklo Plans July 4 Microreactor Criticality Test, Cwm LLC Raises Stake 59.1%
Oklo’s Aurora microreactor at Idaho National Lab is set to demonstrate criticality by July 4, 2026, yet the company remains pre-revenue without an NRC license, limiting cash generation. Cwm LLC boosted its position 59.1% to 23,974 shares, while CEO Jacob Dewitte sold 840,000 shares at $82.32, cutting his stake 34.7%.
1. Stellar 2025 Rally and 2026 Investment Case
Oklo’s shares surged approximately 480% between January and mid-October 2025, transforming a $10,000 stake into about $58,000 before pulling back to roughly $23,850 by year-end. Despite having no meaningful revenue, the company’s promise of compact nuclear power for AI data centers has fueled speculative interest. If Oklo repeats 2025’s 238% gain, a $500 purchase today could grow to about $1,690 in a year. However, its status as a pre-revenue entity with no commercial-scale operating license makes any investment a high-risk, high-reward proposition for those with a long time horizon.
2. Technical and Regulatory Milestones
Oklo is constructing its first Aurora microreactor at the Idaho National Laboratory under DOE oversight. The facility is scheduled to achieve initial criticality by July 4, 2026, marking a key technical milestone. Yet regulatory approval from the Nuclear Regulatory Commission remains outstanding; without an NRC license to build and operate commercially, Oklo cannot generate revenue at scale. Investors should watch both the demonstration event and the timing of the NRC’s decision, as each will strongly influence the company’s valuation trajectory.
3. Institutional Accumulation Trends
In the third quarter of 2025, Cwm LLC boosted its Oklo stake by 59.1%, acquiring 8,902 additional shares to reach 23,974 shares worth $2.68 million. Other notable moves include Fourth Dimension Wealth LLC increasing its position by 125% with an extra 250 shares, and several advisory firms initiating small stakes valued between $25,000 and $28,000. Institutions and hedge funds collectively own more than 85% of Oklo’s outstanding stock, indicating that professional investors are positioning for future milestones despite the company’s current cash burn and revenue delays.
4. Analyst Opinions and Insider Activity
Research firms hold mixed views: two have Strong Buy ratings, nine Buy, seven Hold and three Sell, resulting in a consensus Hold rating with an average price objective near $103. Sell-side forecasts anticipate a full-year loss per share of about $8.20 for 2026. Insider selling has been significant: CEO Jacob Dewitte sold 840,000 shares in late December for proceeds totaling $69.15 million, reducing his holding by 34.7%, while another executive offloaded 5,864 shares. Insider ownership now stands at roughly 18.9%, a factor investors may interpret as cautious sentiment from management.